Clopidogrel Drug Profile

What is Clopidogrel?

Clopidogrel is an oral antiplatelet medication that belongs to a class of drugs called P2Y12 receptor antagonists. It is primarily prescribed to prevent blood clots in patients who have experienced cardiovascular events or are at high risk for them. This medication works by reducing the ability of blood platelets to stick together and form dangerous clots in arteries.

Uses

Clopidogrel is prescribed for several cardiovascular conditions:

• Prevention of heart attack and stroke – Used in patients who have already experienced these events to prevent recurrence
• Acute coronary syndrome – Helps manage unstable angina and heart attacks by preventing further clot formation
• Following coronary stent placement – Prevents blood clots from forming around newly placed stents in heart arteries
• Peripheral arterial disease – Reduces clotting risk in patients with blocked arteries in the legs or arms
• Atrial fibrillation – Sometimes used as an alternative to warfarin in patients who cannot take blood thinners

How it works

Clopidogrel prevents blood clots by blocking specific receptors on blood platelets called P2Y12 receptors. When these receptors are blocked, platelets cannot receive signals that would normally cause them to clump together and form clots. The medication must be converted to its active form by liver enzymes before it can effectively inhibit platelet function, which is why it may take several days to reach full effectiveness.

Side effects

Common side effects include:

Submit Your Paper

• Easy bruising
• Minor bleeding (nosebleeds, bleeding gums)
• Stomach pain or upset
• Diarrhea
• Headache
• Dizziness
• Skin rash or itching
• Joint pain

Serious side effects requiring immediate medical attention:

• Severe bleeding that won’t stop
• Blood in urine or stool
• Unusual bleeding or bruising
• Signs of stroke (sudden weakness, vision changes, speech problems)
• Severe allergic reactions with difficulty breathing or swallowing

Warnings and precautions

• Bleeding risk – Patients with active bleeding, history of bleeding disorders, or recent surgery should use this medication with extreme caution
• Genetic factors – Some people have genetic variations that affect how well they metabolize clopidogrel, potentially reducing its effectiveness
• Pregnancy and breastfeeding – Safety during pregnancy has not been established; consult healthcare provider about risks and benefits
• Liver function – Patients with severe liver disease may not convert the medication to its active form effectively
• Surgery considerations – The medication is typically stopped 5-7 days before elective surgery to reduce bleeding risk

Interactions

• Proton pump inhibitors (omeprazole, esomeprazole) – May reduce clopidogrel’s effectiveness by interfering with its activation
• Warfarin and other blood thinners – Significantly increases bleeding risk when used together
• Aspirin – Often prescribed together but increases bleeding risk, especially gastrointestinal bleeding
• NSAIDs (ibuprofen, naproxen) – Increases risk of stomach bleeding when combined with clopidogrel
• Certain antidepressants (SSRIs) – May increase bleeding risk, particularly when combined with other antiplatelet drugs
• CYP2C19 inhibitors (fluconazole, fluvoxamine) – Can reduce the conversion of clopidogrel to its active form
• St. John’s Wort – May alter the metabolism of clopidogrel and affect its effectiveness
• Ginkgo biloba – May increase bleeding risk when combined with antiplatelet medications

Check interactions with the GMJ Interaction Checker

Dosage

The typical adult dosage of clopidogrel is 75 mg once daily, taken with or without food. For acute coronary syndrome, a loading dose of 300-600 mg may be given initially, followed by the standard 75 mg daily maintenance dose. In some cases involving coronary stent placement, the medication may be prescribed in combination with aspirin for a specific duration. The exact dosage and duration of treatment should always be determined by a healthcare provider based on the individual patient’s condition, risk factors, and response to treatment.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).